Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies

Journal of Affective Disorders

Volumn 197, Issue , 2016, Pages 9-20

  Sharma, Ajaykumar N ^a   Da Costa E Silva, Bruno Fernando Borges ^a   Soares, Jair C ^a   Carvalho, André F ^c   Quevedo, Joao ^a,b,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Biomarker; GDNF; IGF 1; Major depressive disorder; Neurorophin; Trophic factors; VEGF

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DULOXETINE; FLUOXETINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SOMATOMEDIN C; TRICYCLIC ANTIDEPRESSANT AGENT; VASCULOTROPIN; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; VASCULOTROPIN A;

BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; GENE EXPRESSION; GERIATRIC DEPRESSION SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTERVIEW; MAJOR DEPRESSION; MEDLINE; MENTAL PATIENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY;

ANTIDEPRESSIVE AGENTS; BIOMARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84960129624     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.02.067     Document Type: Review

References (71)

1. S.E. Arnold, S.X. Xie, Y.Y. Leung, L.S. Wang, M.A. Kling, X. Han, and L.M. Shaw Plasma biomarkers of depressive symptoms in older adults Transl. Psychiatry 2 2012 e65
2. M.A. Bach, Z. Shen-Orr, W.L. Lowe Jr., C.T. Roberts Jr., and D. LeRoith Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain Brain Res. Mol. Brain Res. 10 1 1991 43 48
3. D. Berent, M. Macander, J. Szemraj, A. Orzechowska, and P. Galecki Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins Acta Neurobiol. Exp. (Wars.) 74 1 2014 82 90
4. A.F. Carvalho, C.A. Kohler, R.S. McIntyre, C. Knochel, A.R. Brunoni, M.E. Thase, and M. Berk Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis Psychoneuroendocrinology 62 2015 18 26
5. L.A. Carvalho, V. Bergink, L. Sumaski, J. Wijkhuijs, W.J. Hoogendijk, T.K. Birkenhager, and H.A. Drexhage Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder Transl. Psychiatry 4 2014 e344
6. L.A. Carvalho, J.P. Torre, A.S. Papadopoulos, L. Poon, M.F. Juruena, K. Markopoulou, and C.M. Pariante Lack of clinical therapeutic benefit of antidepressants IS associated overall activation of the inflammatory system J. Affect. Disord. 148 1 2013 136 140
7. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol. Psychiatry 50 4 2001 260 265
8. A. Clark-Raymond, and A. Halaris VEGF and depression: a comprehensive assessment of clinical data J. Psychiatr. Res. 47 8 2013 1080 1087
9. A. Clark-Raymond, E. Meresh, D. Hoppensteadt, J. Fareed, J. Sinacore, and A. Halaris Vascular endothelial growth factor: a potential diagnostic biomarker for major depression J. Psychiatr. Res. 59 2014 22 27
10. M. Deuschle, W.F. Blum, C.J. Strasburger, U. Schweiger, B. Weber, A. Korner, and I. Heuser Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients Psychoneuroendocrinology 22 7 1997 493 503
11. B.S. Diniz, A.L. Teixeira, A.S. Miranda, L.L. Talib, W.F. Gattaz, and O.V. Forlenza Circulating Glial-derived neurotrophic factor IS reduced in late-life depression J. Psychiatr. Res. 46 1 2012 135 139
12. P. Dome, Z. Halmai, J. Dobos, J. Lazary, X. Gonda, I. Kenessey, and G. Faludi Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from An episode of major depression J. Affect. Disord. 136 3 2012 1159 1163
13. P. Dome, Z. Teleki, Z. Rihmer, L. Peter, J. Dobos, I. Kenessey, and B. Dome Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul Mol. Psychiatry 14 5 2009 523 531
14. C.H. Duman, L. Schlesinger, R. Terwilliger, D.S. Russell, S.S. Newton, and R.S. Duman Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise Behav. Brain Res. 198 2 2009 366 371
15. R.S. Duman, E.J. Heninger Gr Fau-Nestler, and E.J. Nestler A molecular and cellular theory of depression Arch. Gen. Psychiatry 54 1997 0003-990X (Print)
16. V. Duric, and R.S. Duman Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes Cell Mol. Life Sci. 70 1 2013 39 53
17. Y. Dwivedi, H.S. Rizavi, R.R. Conley, R.C. Roberts, C.A. Tamminga, and G.N. Pandey Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects Arch. Gen. Psychiatry 60 8 2003 804 815
18. B. Elfving, H.N. Buttenschon, L. Foldager, P.H. Poulsen, M.B. Grynderup, A.M. Hansen, and O. Mors Depression and BMI influences the serum vascular endothelial growth factor level Int. J. Neuropsychopharmacol. 17 9 2014 1409 1417
19. R.T. Emeny, M. Bidlingmaier, M.E. Lacruz, B. Linkohr, A. Peters, M. Reincke, and K.H. Ladwig Mind over hormones: sex differences in associations of well-being with IGF-I, IGFBP-3 and physical activity in the KORA-age study Exp. Gerontol. 59 2014 58 64
20. M. Fornaro, G. Rocchi, A. Escelsior, P. Contini, M. Ghio, S. Colicchio, and M. Martino VEGF plasma level variations in duloxetine-treated patients with major depression J. Affect. Disord. 151 2 2013 590 595
21. N.M. Fournier, and R.S. Duman Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression Behav. Brain Res. 227 2 2012 440 449
22. B. Franz, D.J. Buysse, C.R. Cherry, N.S. Gray, V.J. Grochocinski, E. Frank, and D.J. Kupfer Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication J. Psychiatr. Res. 33 2 1999 121 127
23. P. Galecki, E. Galecka, M. Maes, A. Orzechowska, D. Berent, M. Talarowska, and J. Szemraj Vascular endothelial growth factor gene (VEGFA) polymorphisms May serve as prognostic factors for recurrent depressive disorder development Prog. Neuropsychopharmacol. Biol. Psychiatry 45 2013 117 124
24. P. Galecki, A. Orzechowska, D. Berent, M. Talarowska, K. Bobinska, E. Galecka, and J. Szemraj Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder J. Affect. Disord. 147 1-3 2013 144 149
25. J.P. Guilloux, G. Douillard-Guilloux, R. Kota, X. Wang, A.M. Gardier, K. Martinowich, and E. Sibille Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression Mol. Psychiatry 17 11 2012 1130 1142
26. Z. Halmai, P. Dome, J. Dobos, X. Gonda, A. Szekely, M. Sasvari-Szekely, and J. Lazary Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study J. Affect. Disord. 144 3 2013 269 273
27. B.A. Hoshaw, J.E. Malberg, and I. Lucki Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects Brain Res. 1037 1-2 2005 204 208
28. J. Iga, S. Ueno, K. Yamauchi, S. Numata, S. Tayoshi-Shibuya, S. Kinouchi, and T. Ohmori Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 31 3 2007 658 663
29. J. Isung, S. Aeinehband, F. Mobarrez, B. Martensson, P. Nordstrom, M. Asberg, and J. Jokinen Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters Transl. Psychiatry 2 2012 e196
30. J. Isung, F. Mobarrez, P. Nordstrom, M. Asberg, and J. Jokinen Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide World J. Biol. Psychiatry 13 6 2012 468 473
31. K.G. Kahl, S. Bens, K. Ziegler, S. Rudolf, A. Kordon, L. Dibbelt, and U. Schweiger Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder Psychoneuroendocrinology 34 3 2009 353 357
32. F. Karege, G. Perret, G. Bondolfi, M. Schwald, G. Bertschy, and J.M. Aubry Decreased serum brain-derived neurotrophic factor levels in major depressed patients Psychiatry Res. 109 2 2002 143 148
33. F. Karege, G. Vaudan, M. Schwald, N. Perroud, and R. La Harpe Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs Brain Res. Mol. Brain Res. 136 1-2 2005 29 37
34. A. Kopczak, G.K. Stalla, M. Uhr, S. Lucae, J. Hennings, M. Ising, and S. Kloiber IGF-I in major depression and antidepressant treatment response Eur. Neuropsychopharmacol. 25 6 2015 864 872
35. Z. Kotan, E. Sarandol, E. Kirhan, G. Ozkaya, and S. Kirli Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features Ther. Adv. Psychopharmacol. 2 2 2012 65 74
36. B.H. Lee, and Y.K. Kim Increased plasma VEGF levels in major depressive OR manic episodes in patients with mood disorders J. Affect. Disord. 136 1-2 2012 181 184
37. H.Y. Lee, and Y.K. Kim Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants Neuropsychobiology 57 4 2008 194 199
38. K.P. Lesch, R. Rupprecht, U. Muller, H. Pfuller, and H. Beckmann Insulin-like growth factor I in depressed patients and controls Acta Psychiatr. Scand. 78 6 1988 684 688
39. F. Lin, J. Suhr, S. Diebold, and K.L. Heffner Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults Psychoneuroendocrinology 42 2014 118 123
40. P.Y. Lin, and P.T. Tseng Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study J. Psychiatr. Res. 2015 1879-1379 (Electronic)
41. Q. Liu, H.Y. Zhu, B. Li, Y.Q. Wang, J. Yu, and G.C. Wu Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression J. Affect. Disord. 141 2-3 2012 367 372
42. T.M. Michel, S. Frangou, S. Camara, D. Thiemeyer, J. Jecel, T. Tatschner, and E. Grunblatt Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study Eur. Psychiatry 23 6 2008 413 420
43. D. Michelson, J. Amsterdam, J. Apter, M. Fava, P. Londborg, R. Tamura, and L. Pagh Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment Psychoneuroendocrinology 25 2 2000 169 177
44. V.S. Naumenko, D.V. Bazovkina, A.A. Semenova, A.S. Tsybko, T.V. Il'chibaeva, E.M. Kondaurova, and N.K. Popova Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders J. Neurosci. Res. 91 12 2013 1628 1638
45. S.S. Newton, N.M. Fournier, and R.S. Duman Vascular growth factors in neuropsychiatry Cell Mol. Life Sci. 70 10 2013 1739 1752
46. M.M. Nowacka, and E. Obuchowicz Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action Neuropeptides 46 1 2012 1 10
47. K. Otsuki, S. Uchida, T. Watanuki, Y. Wakabayashi, M. Fujimoto, T. Matsubara, and Y. Watanabe Altered expression of neurotrophic factors in patients with major depression J. Psychiatr. Res. 42 14 2008 1145 1153
48. P. Pallavi, R. Sagar, M. Mehta, S. Sharma, A. Subramanium, F. Shamshi, and A.K. Mukhopadhyay Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity J. Affect. Disord. 150 2 2013 415 423
49. G. Paslakis, W.F. Blum, and M. Deuschle Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression Med. Hypotheses 79 2 2012 222 225
50. A.R. Rosa, B.N. Frey, A.C. Andreazza, K.M. Cereser, A.B. Cunha, J. Quevedo, and F. Kapczinski Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder Neurosci. Lett. 407 2 2006 146 150
51. S. Rueda Alfaro, M. Serra-Prat, E. Palomera, I. Falcon, I. Cadenas, X. Boquet, and M. Puig Domingo Hormonal determinants of depression and cognitive function in independently-living elders Endocrinol. Nutr. 55 9 2008 396 401
52. E. Scarr, M.J. Millan, S. Bahn, A. Bertolino, C.W. Turck, S. Kapur, and B. Dean Biomarkers for psychiatry: the journey from fantasy to fact, a report of the 2013 CINP think tank Int. J. Neuropsychopharmacol. 2015 10.1093/ijnp/pyv042
53. G. Scola, and A.C. Andreazza The role of neurotrophins in bipolar disorder Prog. Neuro-Psychopharmacol. Biol. Psychiatry 56 2015 122 128
54. T. Shibata, H. Yamagata, S. Uchida, K. Otsuki, T. Hobara, F. Higuchi, and Y. Watanabe The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients Prog. Neuropsychopharmacol. Biol. Psychiatry 43 2013 222 229
55. C. Sievers, M.K. Auer, J. Klotsche, A.P. Athanasoulia, H.J. Schneider, M. Nauck, and H.J. Grabe IGF-I levels and depressive disorders: results from the study of health in Pomerania (SHIP) Eur. Neuropsychopharmacol. 24 6 2014 890 896
56. E. Szczesny, J. Slusarczyk, K. Glombik, B. Budziszewska, M. Kubera, W. Lason, and A. Basta-Kaim Possible contribution of IGF-1 to depressive disorder Pharm. Rep. 65 6 2013 1622 1631
57. M. Takebayashi, R. Hashimoto, K. Hisaoka, M. Tsuchioka, and H. Kunugi Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders J. Neural Transm. 117 9 2010 1119 1122
58. M. Takebayashi, K. Hisaoka, A. Nishida, M. Tsuchioka, I. Miyoshi, T. Kozuru, and S. Yamawaki Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders Int. J. Neuropsychopharmacol. 9 5 2006 607 612
59. D. Taliaz, N. Stall, D.E. Dar, and A. Zangen Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis Mol. Psychiatry 15 1 2010 80 92
60. S.J. Tsai, C.J. Hong, Y.J. Liou, T.J. Chen, M.L. Chen, S.J. Hou, and Y.W. Yu Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder Psychiatry Res. 169 2 2009 113 117
61. P.T. Tseng, Y. Lee, and P.Y. Lin Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 40 2013 334 339
62. N.C. van Varsseveld, C.C. van Bunderen, E. Sohl, H.C. Comijs, B.W. Penninx, P. Lips, and M.L. Drent Serum insulin-like growth factor 1 and late-life depression: a population-based study Psychoneuroendocrinology 54 2015 31 40
63. M. Ventriglia, R. Zanardini, L. Pedrini, A. Placentino, M.G. Nielsen, M. Gennarelli, and L. Bocchio-Chiavetto VEGF serum levels in depressed patients during SSRI antidepressant treatment Prog. Neuropsychopharmacol. Biol. Psychiatry 33 1 2009 146 149
64. M. Viikki, S. Anttila, O. Kampman, A. Illi, M. Huuhka, E. Setala-Soikkeli, and E. Leinonen Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression Neurosci. Lett. 477 3 2010 105 108
65. F.R. Walker A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 67 2013 304 317
66. X. Wang, Z. Hou, Y. Yuan, G. Hou, Y. Liu, H. Li, and Z. Zhang Association study between plasma GDNF and cognitive function in late-onset depression J. Affect Disord. 132 3 2011 418 421
67. J.L. Warner-Schmidt, and R.S. Duman VEGF as a potential target for therapeutic intervention in depression Curr. Opin. Pharm. 8 1 2008 14 19
68. B. Weber-Hamann, W.F. Blum, J. Kratzsch, M. Gilles, I. Heuser, and M. Deuschle Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment Pharmacopsychiatry 42 1 2009 23 28
69. X. Zhang, B. Ru, W. Sha, W. Xin, H. Zhou, and Y. Zhang Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder Asia PAC Psychiatry 6 3 2014 302 307
70. X. Zhang, Z. Zhang, W. Sha, C. Xie, G. Xi, H. Zhou, and Y. Zhang Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients J. Affect. Disord. 126 1-2 2010 326 329
71. X. Zhang, Z. Zhang, C. Xie, G. Xi, H. Zhou, Y. Zhang, and W. Sha Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients Prog. Neuropsychopharmacol. Biol. Psychiatry 32 3 2008 886 890